FTD
Clinical trials for FTD explained in plain language.
Never miss a new study
Get alerted when new FTD trials appear
Sign up with your email to follow new studies for FTD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot gene therapy could slow genetic dementia – first human trial underway
Disease control Recruiting nowThis study tests a new gene therapy called AVB-101 for people with a genetic form of frontotemporal dementia (FTD-GRN). The treatment is given once, directly into the brain, to restore a missing protein and potentially slow or stop the disease. About 18 adults aged 30-75 with ear…
Matched conditions: FTD
Phase: PHASE1, PHASE2 • Sponsor: AviadoBio Ltd • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Could magnetic pulses ease frontotemporal dementia?
Symptom relief Recruiting nowThis study tests whether a gentle magnetic brain stimulation called rTMS is safe and helpful for people with frontotemporal dementia (FTLD) or those at risk. About 120 participants will receive either real or placebo stimulation for 2 weeks, then everyone gets real stimulation. R…
Matched conditions: FTD
Phase: NA • Sponsor: Università degli Studi di Brescia • Aim: Symptom relief
Last updated May 13, 2026 15:59 UTC
-
Scientists hunt for hidden markers in brain diseases
Knowledge-focused Recruiting nowThis study aims to find new biological markers for diseases like Alzheimer's, Parkinson's, and ALS by analyzing the genes, proteins, and metabolism of 1,200 patients. Researchers will use advanced technology to look for patterns that could help with earlier diagnosis, better prog…
Matched conditions: FTD
Sponsor: Ospedale Policlinico San Martino • Aim: Knowledge-focused
Last updated May 17, 2026 01:47 UTC
-
Scientists hunt for hidden clues to spot ALS and FTD earlier
Knowledge-focused Recruiting nowThis study aims to find biological markers (biosignatures) in body fluids and tissues that can help doctors diagnose ALS and FTD more accurately and earlier. Researchers will analyze samples from 230 adults using advanced techniques to detect abnormal proteins and other changes. …
Matched conditions: FTD
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated May 04, 2026 16:31 UTC